Massive fundic gland polyposis caused by chronic proton pump inhibitor therapy;Tartós protonpumpagátló kezelés hatására kialakuló masszív fundusmirigy-polyposis

Orvosi Hetilap

Volumn 153, Issue 9, 2012, Pages 351-356

  Hegedus, Ivett ^a   Csizmadia, Csaba ^b   Lomb, Zoltán ^a   Cseke, László ^a   Enkh Amar, Yadamsuren ^a   Pajor, László ^a   Bogner, Barna ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b I Belgyógyászati Klinika ^*  (Hungary)

Author keywords

Fundic gland polyposis; Proton pump inhibitor therapy

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CASE REPORT; ENDOSCOPIC SURGERY; FEMALE; FUNDIC GLAND POLYPOSIS; GASTROSCOPY; HUMAN; STOMACH GLAND POLYP; TOTAL STOMACH RESECTION;

FEMALE; GASTRECTOMY; GASTRIC FUNDUS; GASTROINTESTINAL TRANSIT; HUMANS; MIDDLE AGED; POLYPS; PROTON PUMP INHIBITORS; STOMACH DISEASES;

EID: 84857522089     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2012.29313     Document Type: Article

References (40)

1. Raghunath, A. S., O'Morain, C., McLoughlin, R. C.: Review article: the long-term use of proton pump inhibitors. Aliment. Pharmacol. Ther., 2005, 22 (Suppl. 1), 55-63. (Pubitemid 41153080)
2. Graham, J. R.: Gastric polyposis: onset during long-term therapy with omeprazole. Med. J. Aust., 1992, 157, 287-288.
3. Jalving, M., Koornstra, J. J., Wesseling, J., et al.: Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment. Pharmacol. Ther., 2006, 24, 1341-1348. (Pubitemid 44571564)
4. Vieth, M., Stolte, M.: Fundic gland polyps are not induced by proton pump inhibitor therapy. Am. J. Clin. Pathol., 2001, 116, 716-720. (Pubitemid 34453213)
5. Choundry, U., Boyce, H. W. Jr., Coppola, D.: Proton pump inhibitor- associated gastric polyps. A retrospective analysis of their frequency, and endoscopic, histologic and ultrastructural characteristics. Am. J. Clin. Pathol., 1998, 110, 615-621. (Pubitemid 28491966)
6. Freeman, H. J.: Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World. J. Gastroenterol., 2008, 14, 1318-1320. (Pubitemid 351425207)
7. Iida, M., Yao, T., Watanabe, H., et al.: Spontaneous disappearance of fundic gland polyposis: report of three cases. Gastroenterology, 1980, 79, 725-728. (Pubitemid 10009565)
8. Ally, M. R., Veerappan, G. R., Maydonovitch, C. L., et al.: Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig. Dis. Sci., 2009, 54, 2617-2622.
9. Oberhuber, G., Stolte, M.: Gastric polyps: an update of their pathology and biological significance. Virchows Arch., 2000, 437, 581-590. (Pubitemid 32003087)
10. Odze, R. D., Marcial, M. A., Antonioli, D.: Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and mib-1 immunhistochemistry. Hum. Pathol., 1996, 27, 896-903. (Pubitemid 26304567)
11. Abraham, S. C., Nobukawa, B., Giardiello, F. M., et al.: Fundic gland polyps in familial adenomatous polyposis. Neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am. J. Pathol., 2000, 157, 747-754. (Pubitemid 32109367)
12. Marcial, M. A., Villafaña, M., Hernandez-Denton, J., et al.: Fundic gland polyps: prevalence and clinicopathologic features. Am. J. Gastroenterol., 1993, 88, 1711-1713. (Pubitemid 23298119)
13. Zelter, A., Fernández, J. L., Bilder, C., et al.: Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig. Dis. Sci., 2011, 56, 1743-1748.
14. Lee, R. G., Burt, R. W.: The histopathology of fundic gland polyps of the stomach. Am. J. Clin. Pathol., 1986, 86, 498-503. (Pubitemid 16006877)
15. Iida, M., Yao, T., Watanabe, H., et al.: Fundic gland polyposis in patients without familial adenomatosis coli: its incidence and clinical features. Gastroenterology, 1984, 86, 1437-1442. (Pubitemid 14147935)
16. Burt, R. W.: Gastric fundic gland polyps. Gastroenterology, 2003, 125, 1462-1469. (Pubitemid 37409766)
17. Rubio, C. A., Befrits, R., Österberg, J., et al.: Massive fundic gland polyposis in a patient receiving protracted proton-pump inhibitor medication. Anticancer. Res., 2010, 30, 261-264.
18. Torbenson, M., Lee, J-H., Cruz-Correa, M. és mtsai: Sporadic fundic gland polyps: a clinical, histological and molecular analysis. Mod. Pathol., 2002, 15, 718-723. (Pubitemid 34787307)
19. Hizawa, K., Iida, M., Matsumoto, T., et al.: Natural history of fundic gland polyposis without familial adenomatosis coli: follow-up observations in 31 patients. Radiology, 1993, 189, 429-432. (Pubitemid 23321423)
20. Abraham, S. C., Park, S. J., Mugartegui, L., et al.: Sporadic fundic gland polyps with epithelial dysplasia. Evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am. J. Pathol., 2002, 161, 1735-1742. (Pubitemid 35265531)
21. Abraham, S. C., Nobukawa, B., Giardiello, F. M., et al.: Sporadic fundic gland polyps. Common gastric polyps arising through activating mutations in the β-catenin gene. Am. J. Pathol., 2001, 158, 1005-1010. (Pubitemid 32221792)
22. Jalving, M., Koornstra, J. J., Götz, J. M., et al.: High grade dysplasia in sporadic fundic gland polyps: a case report and a review of the literature. Eur. J. Gastroenterol. Hepatol., 2003, 15, 1229-1233. (Pubitemid 38174849)
23. Attard, T. M., Yardley, J. H., Cuffari, C.: Gastric polyps in pediatrics: an 18-year hospital-based analysis. Am. J. Gastroenterol., 2002, 97, 298-301. (Pubitemid 34160753)
24. Stolte, M., Vieth, M., Ebert, M. P. A.: High grade dysplasia in sporadic fundic gland polyps: clinically releavant or not? Eur. J. Gastroenterol. Hepatol., 2003, 15, 1153-1156. (Pubitemid 38174837)
25. Kuipers, E. J.: Proton pump inhibitors and gastric neoplasia. Gut, 2006, 55, 1217-1221. (Pubitemid 44277346)
26. Hornick, J. L., Odze, R. D.: Adenomatous polyposis syndrome. In: Surgical pathology of the GI tract, liver, biliary tract and pancreas. Second edition (Chapter 19: Polyps of the large intestine). Eds.: Odze, R. D., Goldblum, J. R. Elsevier Inc., 2009, 514-516.
27. Driman, D. K., Wright, C., Tougas, G., et al.: Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig. Dis. Sci., 1996, 41, 2039-2047. (Pubitemid 26366806)
28. Lee, S. W., Lieberman, D. A., Ippoliti, A. F., et al.: Changes in the parietal cell mass after long term therapy with high dose omeprazole in Barrett's esophagus (BE): a two year prospective study. Gastroenterology, 1996, 110, A173
29. Cats, A., Schenk, B. E., Bloemena, E., et al.: Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum. Pathol., 2000, 31, 684-690. (Pubitemid 30445471)
30. Synnerstad, I., Holm, L.: Omeprazole induces high intraglandular pressure in the rat gastric mucosa. Gastroenterology, 1997, 112, 1221-1230. (Pubitemid 27157534)
31. Solcia, E., Fiocca, R., Havu, N., et al.: Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion, 1992, 51 (Suppl 1), 82-92.
32. Klinkenberg-Knol, E. C., Nelis, F., Dent, J., et al.: Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology, 2000, 118, 661-669. (Pubitemid 30171615)
33. Stolte, M., Meining A., Schmitz, J. M., et al.: Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patient with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther., 1998, 12, 247-253. (Pubitemid 28160019)
34. Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., et al.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med., 1996, 304, 1018-1022. (Pubitemid 26123777)
35. Kuipers, E. J., Nelis, G. F., Klinkenberg-Knol, E. C., et al.: Cure of Helicobacter pylori infection in patients with reflux esophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut, 2004, 53, 12-20. (Pubitemid 38083004)
36. Malfertheiner, P., Megraud, F., O'Morain, C., et al., The European Helicobacter Study Group (EHSG): Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56, 772-781. (Pubitemid 46854190)
37. Panter, S. J., O'Flanagan, H., Bramble, M. G., et al.: Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome. Aliment. Pharmacol. Ther., 2004, 19, 981-988. (Pubitemid 38657378)
38. Bramble, M. G., Suvakovic, Z., Hungin, A. P. S.: Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut, 2000, 46, 464-467. (Pubitemid 30305808)
39. Jacobson, B. C., Ferris, T. G., Shea, T. L., et al.: Who is using chronic acid suppression therapy and why? Am. J. Gastroenterol., 2003, 98, 51-58. (Pubitemid 36135169)
40. Pap, Á.: Side effects of long-term treatment with proton pump inhibitors [A hosszú távú protonpumpagátló kezelés mellékhatásai.] LAM, 2009, 19, 489-492.